Group 1 - The company is currently in the research and development stage for its positive photoresist (specifically LCD photoresist) products and has not yet entered production [2] - The development of the photo-sensitive polyimide (PSPI) photoresist products will be advanced based on R&D progress and market conditions, indicating that the timeline for commercialization remains uncertain [2]

Group 1: Institutional Trading Insights - On the institutional trading leaderboard, 28 stocks were listed, with 16 experiencing net buying and 13 facing net selling [1] - The top three stocks with the highest institutional buying were: Limin Co., Ltd. (75.16 million), Saiseng Pharmaceutical (71.78 million), and Haike Xinyuan (37.08 million) [1] Group 2: Stock Performance and Market Trends - Limin Co., Ltd. saw a decrease of 9.98% with a net buying amount of 105 million [2] - Saiseng Pharmaceutical experienced a significant increase of 19.97% with a net buying amount of 57.49 million [2] - Haike Xinyuan had a notable rise of 20.00% with a net buying amount of 37.09 million [2] Group 3: Industry Developments - Saiseng Pharmaceutical's subsidiary, Junyuan Pharmaceutical, produces ursodeoxycholic acid tablets, indicating a focus on relevant production capabilities [3] - The solid-state battery sector is advancing, with companies like Kexin and Taiblue New Energy developing new materials and products for battery applications [3] - The Ministry of Industry and Information Technology is expected to conduct a mid-term review of solid-state battery projects by the end of 2025, with key developments anticipated between 2025 and 2026 [3] Group 4: Market Opportunities in Advanced Packaging - The advanced packaging market is projected to grow from 30.4 billion in 2020 to approximately 47.5 billion by 2026, increasing its market share from 45% to 50% [5]